SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
NuVim, Inc. (NUVM) trades at a trailing P/E of 22.5. Trailing earnings yield is 4.44%.
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (22.5); earnings yield beats bond yields (4.44%).
- Trailing Earnings Yield 4.44% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
Overall SharesGrow Score: 22/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NUVM
Valuation Multiples
P/E (TTM)22.5
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio890.28
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.44%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.00 |
$2.13K |
$-44.41K |
-2087.9% |
| 2017 |
$0.00 |
$1.06K |
$-26.7K |
-2512.1% |
| 2018 |
$0.00 |
$1.33K |
$-16.54K |
-1244.7% |
| 2019 |
$0.00 |
$1.02K |
$-22.42K |
-2196.1% |
| 2020 |
$0.00 |
$1.3K |
$-13.47K |
-1035% |
| 2021 |
$0.00 |
$1.21K |
$-21.8K |
-1804.8% |
| 2022 |
$0.00 |
$920.00 |
$-18.94K |
-2058.8% |
| 2023 |
$0.00 |
$2.21K |
$-26.35K |
-1192.2% |
| 2024 |
$0.00 |
$1.45K |
$-20.31K |
-1403.3% |
| 2025 |
$0.00 |
$600.00 |
$-19.04K |
-3173% |
